Availability and Need of Computerized Systems and Tools to Anticipate and Monitor Supply of Bicillin® L-A: Summary of Preliminary Survey Results and Next Steps
During the past few years, occasional shortages in the supply and availability of Bicillin® L-A for the treatment of syphilis in the United States have resulted from manufacturing and distribution issues. STD Programs can reduce the impact of manufacturing shortages by using effective and efficient systems and tools to monitor and predict future Bicillin® L-A supply and distribution. From September through November 2017, NCSD, in consultation with the Centers for Disease Control and Prevention (CDC), Division of STD Prevention (DSTDP), conducted a survey among CDC directly funded STD Programs [STD Project Areas and US-affiliated Pacific Island (USAPI) Jurisdictions] to assess the availability of computerized systems and tools for preventing emergency shortages.
Of the 59 STD project areas and 6 USAPI jurisdictions, 83% (54/65) responded to the survey. Preliminary findings indicate:
NCSD, in collaboration with the CDC DSTDP, will use these survey results to help increase the capacity of STD Programs to monitor and track their current supply of Bicillin® L-A and use tools to project future Bicillin® L-A needs. During 2018, NCSD and CDC anticipates conducting the following activities: